CAN
MRNA icon

Cetera Advisor Networks’s Moderna MRNA Stock Holding History

Cetera Advisor Networks’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$5.55M Buy
52,057
+21,521
+70% +$2.17M 0.03% 590
2023
Q4 		$3.04M Buy
30,536
+9,016
+42% +$758K 0.02% 795
2023
Q3 		$2.22M Buy
21,520
+2,803
+15% +$313K 0.01% 845
2023
Q2 		$2.27M Buy
18,717
+1,975
+12% +$263K 0.02% 806
2023
Q1 		$2.57M Sell
16,742
-453
-3% -$74.7K 0.02% 746
2022
Q4 		$3.09M Buy
17,195
+87
+0.5% +$14.2K 0.03% 631
2022
Q3 		$2.02M Sell
17,108
-3,046
-15% -$462K 0.03% 589
2022
Q2 		$2.88M Buy
20,154
+4,609
+30% +$659K 0.04% 468
2022
Q1 		$2.68M Sell
15,545
-2,507
-14% -$422K 0.03% 522
2021
Q4 		$4.58M Buy
18,052
+1,154
+7% +$337K 0.06% 323
2021
Q3 		$6.5M Sell
16,898
-205
-1% -$75.6K 0.09% 240
2021
Q2 		$4.02M Buy
17,103
+5,574
+48% +$996K 0.06% 326
2021
Q1 		$1.51M Sell
11,529
-1,175
-9% -$170K 0.03% 443
2020
Q4 		$1.33M Buy
12,704
+490
+4% +$49.6K 0.03% 439
2020
Q3 		$864K Buy
12,214
+4,919
+67% +$343K 0.02% 526
2020
Q2 		$468K Buy
+7,295
New +$400K 0.01% 719

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cetera Advisor Networks's MRNA Position: Q1 2024 in Review

Cetera Advisor Networks increased its Moderna (MRNA) stake by 70% in Q1 2024, buying an estimated $2.17M and bringing the position to 52,057 shares worth $5.55M. The position accounts for 0.03% of the portfolio, ranked #590.

Cetera Advisor Networks first reported a position in MRNA in Q2 2020 and has held it in 16 quarters since. The position peaked at $6.5M in Q3 2021. 903 funds tracked by Wall St. Rank hold MRNA as of Q1 2024.

  • Cetera Advisor Networks held 52,057 shares of Moderna worth $5.55M as of Q1 2024.
  • Cetera Advisor Networks bought 21,521 Moderna shares in Q1 2024, an estimated $2.17M.
  • Moderna made up 0.03% of Cetera Advisor Networks's portfolio in Q1 2024, its #590 holding.
  • Cetera Advisor Networks first reported a position in Moderna in Q2 2020 and has held it in 16 quarters since.
  • Cetera Advisor Networks's Moderna position peaked at $6.5M in Q3 2021.
  • 903 funds tracked by Wall St. Rank held Moderna as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.